CINC Stock
0
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
Market Cap
0
LOW - HIGH [24H]
0.0000
-
0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0
Price Chart
CINC Financial and Trading Overview
| stock price | |
| Previous Close | 29.06 |
| Open | 29.17 |
| Bid | 0 x 800 |
| Ask | 0 x 800 |
| Day's Range | 29.02 - 29.35 |
| 52 Week Range | 10.53 - 43.15 |
| Volume | 0 |
| Avg. Volume | 634.18K |
| Market Cap | 1.27B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41 |
CINC Valuation Measures
| Enterprise Value | 749.29M |
| Trailing P/E | N/A |
| Forward P/E | -11.486166 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.4506662 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 96.08% |
| S&P500 52-Week Change | 0.082% |
| 52 Week High | 43.15 |
| 52 Week Low | 10.53 |
| 50-Day Moving Average | 25.59 |
| 200-Day Moving Average | 25.14 |
CINC Share Statistics
| Avg. Volume (3 month) | 634.18K |
| Avg. Daily Volume (10-Days) | 1.09M |
| Shares Outstanding | 43.76M |
| Float | 17.91M |
| Short Ratio | 0.41 |
| % Held by Insiders | 11.99% |
| % Held by Institutions | 94.11% |
| Shares Short | 338.64K |
| Short % of Float | 1.32% |
| Short % of Shares Outstanding | 0.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.25% |
| Return on Equity (ttm) | -26.91% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -88094024 |
| Diluted EPS (ttm) | -2.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 522.5M |
| Total Cash Per Share (mrq) | 11.94 |
| Total Debt (mrq) | 0 |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 51.959 |
| Book Value Per Share (mrq) | 11.858 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64272704 |
| Levered Free Cash Flow (ttm) | -49497008 |
Profile of
| Country | |
| State | MA |
| City | Waltham |
| Address | City Point |
| ZIP | 02451 |
| Phone | 844 531 1834 |
| Website | https://www.cincor.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts. As of February 23, 2023, CinCor Pharma, Inc. operates as a subsidiary of AstraZeneca Finance and Holdings Inc..
Q&A For Stock
What is a current CINC stock price?
CINC stock price today per share is .
How to purchase stock?
You can buy CINC shares on the exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is CINC.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
CINC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}